Last reviewed · How we verify
Bronchoalveolar Lavage and Local Amikacin Injection — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Bronchoalveolar Lavage and Local Amikacin Injection (Bronchoalveolar Lavage and Local Amikacin Injection) — Shanghai Pulmonary Hospital, Shanghai, China.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Bronchoalveolar Lavage and Local Amikacin Injection TARGET | Bronchoalveolar Lavage and Local Amikacin Injection | Shanghai Pulmonary Hospital, Shanghai, China | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Bronchoalveolar Lavage and Local Amikacin Injection CI watch — RSS
- Bronchoalveolar Lavage and Local Amikacin Injection CI watch — Atom
- Bronchoalveolar Lavage and Local Amikacin Injection CI watch — JSON
- Bronchoalveolar Lavage and Local Amikacin Injection alone — RSS
Cite this brief
Drug Landscape (2026). Bronchoalveolar Lavage and Local Amikacin Injection — Competitive Intelligence Brief. https://druglandscape.com/ci/bronchoalveolar-lavage-and-local-amikacin-injection. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab